Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Working Capital/Sales

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.882.391.742.292.64

What is the latest Working Capital/Sales ratio of MEDICAMEN BIOTECH ?

The latest Working Capital/Sales ratio of MEDICAMEN BIOTECH is 1.88 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.88
Mar20242.39
Mar20231.74
Mar20222.29
Mar20212.64

How is Working Capital/Sales of MEDICAMEN BIOTECH Trending?

Years Working Capital/Sales % Change
Mar2025 1.88
-21.34
Mar2024 2.39
37.36
Mar2023 1.74
-24.02
Mar2022 2.29
-13.26
Mar2021 2.64 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare Working Capital/Sales ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹344.5 Cr -1.2% 6.4% -44.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,848.0 Cr 11.6% 0.7% -0.4% Stock Analytics
DIVIS LABORATORIES ₹172,697.0 Cr 2.3% 8.5% 8.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,859.0 Cr 1.8% -1.8% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹110,421.0 Cr 0.5% 3.2% 13.3% Stock Analytics
CIPLA ₹105,811.0 Cr 1.2% 5.4% -13.7% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-1.2%

6.4%

-44.3%

SENSEX

-1%

2.2%

-3.6%


You may also like the below Video Courses